Thermo Fisher Scientific to Showcase Anatomical Pathology Applications
|
By LabMedica International staff writers Posted on 12 Sep 2011 |
|
Image: The Cryostar NX70 Cryostat (Photo courtesy of Thermo Fisher Scientific).
Thermo Fisher Scientific (Runcorn, United Kingdom) will display its latest anatomical pathology solutions at the Institute of Biomedical Science (IBMS) Congress 2011 to be held at the International Convention Center (ICC) Birmingham from September 26-28, 2011.
The anatomical pathology solutions to be exhibited include the Thermo Scientific next generation STP 420ES tissue processor, the Cryostar NX70 cryostat, and SecureSette tissue embedding cassettes.
The latest STP 420ES tissue processor is suitable for high-throughput tissue processing. It enables faster turnaround times for same-day diagnosis and leaner workflows through operational flexibility. Using a dual-chamber design, which features rotational agitation that increases flow of traditional reagents by sevenfold to reduce processing times, the STP 420ES can process up to 420 cassettes per run. Holding 360 and 60 cassettes in the first and second chambers respectively, the second chamber allows independent processing of stat samples, as well as special or difficult tissues, without disrupting routine workflow or requiring the use of a second instrument.
The new CryoStar NX70 Cryostat offers better sectioning quality and increased user comfort. It accommodates a wide range of cryotomy applications for both clinical and research use. Its special features include rapid response temperature control and an innovative knife carrier feed to deliver precise section thickness and consistency.
The Thermo Scientific SecureSette tissue cassette enables lean workflow and enhances patient safety. Orientation is maintained throughout tissue processing and embedding, which means that the cassette is not opened until the sample is embedded in paraffin and ready for sectioning.
Quick and reproducible instrument set-up is simple with the CryoStar NX70’s intuitive LCD display and electronic touch-screen, together with joystick control. Fine adjustment specimen orientation on all axes enables fast and easy specimen alignment. The innovative temperature control system adjusts quickly to changes in settings, enabling rapid cooling, as well as consistent and precise temperature control. Three user-defined favorites enable frequently used temperature settings to be instantly recalled.
During the IBMS congress, Thermo Fisher will also demonstrate products from its immunohistochemistry (IHC) range, including the Thermo Scientific Autostainer and Quanto Reagents. These products offer rapid turnaround times and a flexible, total IHC workflow solution. In addition, PrintMate and SlideMate, the latest additions to Thermo Fisher's slide labeling and tracking product ranges will be presented.
Related Links:
Thermo Fisher Scientific
Institute of Biomedical Science
Institute of Biomedical Science Congress
The anatomical pathology solutions to be exhibited include the Thermo Scientific next generation STP 420ES tissue processor, the Cryostar NX70 cryostat, and SecureSette tissue embedding cassettes.
The latest STP 420ES tissue processor is suitable for high-throughput tissue processing. It enables faster turnaround times for same-day diagnosis and leaner workflows through operational flexibility. Using a dual-chamber design, which features rotational agitation that increases flow of traditional reagents by sevenfold to reduce processing times, the STP 420ES can process up to 420 cassettes per run. Holding 360 and 60 cassettes in the first and second chambers respectively, the second chamber allows independent processing of stat samples, as well as special or difficult tissues, without disrupting routine workflow or requiring the use of a second instrument.
The new CryoStar NX70 Cryostat offers better sectioning quality and increased user comfort. It accommodates a wide range of cryotomy applications for both clinical and research use. Its special features include rapid response temperature control and an innovative knife carrier feed to deliver precise section thickness and consistency.
The Thermo Scientific SecureSette tissue cassette enables lean workflow and enhances patient safety. Orientation is maintained throughout tissue processing and embedding, which means that the cassette is not opened until the sample is embedded in paraffin and ready for sectioning.
Quick and reproducible instrument set-up is simple with the CryoStar NX70’s intuitive LCD display and electronic touch-screen, together with joystick control. Fine adjustment specimen orientation on all axes enables fast and easy specimen alignment. The innovative temperature control system adjusts quickly to changes in settings, enabling rapid cooling, as well as consistent and precise temperature control. Three user-defined favorites enable frequently used temperature settings to be instantly recalled.
During the IBMS congress, Thermo Fisher will also demonstrate products from its immunohistochemistry (IHC) range, including the Thermo Scientific Autostainer and Quanto Reagents. These products offer rapid turnaround times and a flexible, total IHC workflow solution. In addition, PrintMate and SlideMate, the latest additions to Thermo Fisher's slide labeling and tracking product ranges will be presented.
Related Links:
Thermo Fisher Scientific
Institute of Biomedical Science
Institute of Biomedical Science Congress
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
New
PSA Test
Humasis PSA Card
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit
Latest Technology News
- Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
- Paper-Based Biosensor System to Detect Glucose Using Sweat Could Revolutionize Diabetes Management
Channels
Clinical Chemistry
view channel
First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read more
Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more
Molecular Diagnostics
view channel
Liquid Biopsy Assay Detects Recurrence in CRC Patients Prior to Imaging
The detection of circulating tumor DNA (ctDNA) after treatment is a strong indicator of recurrence in colorectal cancer (CRC), but it often goes undetected due to the low traces of ctDNA present in the blood.... Read more
Ultra Fast Synovial Fluid Test Diagnoses Osteoarthritis and Rheumatoid Arthritis In 10 Minutes
Studies indicate that more than 50% of individuals aged 65 and older experience symptoms of osteoarthritis, while rheumatoid arthritis is a serious chronic condition affecting approximately 1 in 100 people... Read more
Hematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read more
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read more
AI-Driven Analysis of Digital Pathology Images to Improve Pediatric Sarcoma Subtyping
Pediatric sarcomas are rare and diverse tumors that can develop in various types of soft tissue, such as muscle, tendons, fat, blood or lymphatic vessels, nerves, or the tissue surrounding joints.... Read more
AI-Based Model Predicts Kidney Cancer Therapy Response
Each year, nearly 435,000 individuals are diagnosed with clear cell renal cell carcinoma (ccRCC), making it the most prevalent subtype of kidney cancer. When the disease spreads, anti-angiogenic therapies... Read more
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
